Literature DB >> 12220106

Histopathology of lupus-like nephritis in Dnase1-deficient mice in comparison to NZB/W F1 mice.

M Jacob1, M Napirei, A Ricken, C Dixkens, H G Mannherz.   

Abstract

Deoxyribonuclease 1 (Dnase1)-deficient mice develop symptoms of Systemic lupus erythematosus (SLE). Here we analysed the renal histopathology of these animals in comparison to F1 hybrids of New Zealand black and white mice (NZB/W F1), an established model of SLE. Animals were divided into three groups according to the presence of anti-nuclear antibodies (ANA) and renal lesions. Groups 1a-1c were healthy, whereas group 2 and 3 were classified as lupus-prone and affected. Subendothelial and/or mesangial immune complex deposits, mesangial and endocapillary proliferation, haematoxylin bodies and platelet aggregation were detected in both mouse strains but were more severe in the NZB/W F1 mice. The lupus nephritis was classified as a proliferating (WHO type III or IV), which appeared to be preceded by a mesangial form (WHO type II). Subclassification of the ANA revealed a high prevalence of anti-nucleosome antibodies in Dnase1-deficient mice, whereas NZB/W F1 mice developed autoantibodies against a broad range of chromatin constituents. Mapping of the murine Dnase1 gene locus to chromosome 16A1-3 did not coincide with one of the reported susceptibility loci in the NZB/W F1 model, although a reduced Dnasel serum and urine activity has been described previously in these mice.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12220106     DOI: 10.1191/0961203302lu242oa

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  8 in total

Review 1.  At the Bench: Neutrophil extracellular traps (NETs) highlight novel aspects of innate immune system involvement in autoimmune diseases.

Authors:  Peter C Grayson; Mariana J Kaplan
Journal:  J Leukoc Biol       Date:  2015-10-02       Impact factor: 4.962

2.  Antigen is required for maturation and activation of pathogenic anti-DNA antibodies and systemic inflammation.

Authors:  Jeganathan Venkatesh; Hajime Yoshifuji; Daisuke Kawabata; Prameladevi Chinnasamy; Anfisa Stanevsky; Christine M Grimaldi; Joel Cohen-Solal; Betty Diamond
Journal:  J Immunol       Date:  2011-03-28       Impact factor: 5.422

Review 3.  RIG-I-Like Receptors and Type I Interferonopathies.

Authors:  Hiroki Kato; Seong-Wook Oh; Takashi Fujita
Journal:  J Interferon Cytokine Res       Date:  2017-05       Impact factor: 2.607

Review 4.  The Role of Anti-DNA Antibodies in the Development of Lupus Nephritis: A Complementary, or Alternative, Viewpoint?

Authors:  Beatrice Goilav; Chaim Putterman
Journal:  Semin Nephrol       Date:  2015-09       Impact factor: 5.299

5.  Expression pattern of the deoxyribonuclease 1 gene: lessons from the Dnase1 knockout mouse.

Authors:  Markus Napirei; Albert Ricken; Dirk Eulitz; Heiko Knoop; Hans Georg Mannherz
Journal:  Biochem J       Date:  2004-06-15       Impact factor: 3.857

6.  Chromatin breakdown by deoxyribonuclease1 promotes acetaminophen-induced liver necrosis: an ultrastructural and histochemical study on male CD-1 mice.

Authors:  Monika Jacob; Hans Georg Mannherz; Markus Napirei
Journal:  Histochem Cell Biol       Date:  2007-05-25       Impact factor: 4.304

7.  Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus.

Authors:  Jason S Knight; Wenpu Zhao; Wei Luo; Venkataraman Subramanian; Alexander A O'Dell; Srilakshmi Yalavarthi; Jeffrey B Hodgin; Daniel T Eitzman; Paul R Thompson; Mariana J Kaplan
Journal:  J Clin Invest       Date:  2013-06-03       Impact factor: 14.808

Review 8.  Origins, structures, and functions of circulating DNA in oncology.

Authors:  A R Thierry; S El Messaoudi; P B Gahan; P Anker; M Stroun
Journal:  Cancer Metastasis Rev       Date:  2016-09       Impact factor: 9.264

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.